Albumin-interferon α2b fusion protein (Anke Biotechnology)
重组人白蛋白干扰素α2b融合蛋白（安徽安科）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAlbumin-interferon α2b fusion protein (Anke Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesAnhui Anke Biotechnology (Group) Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A